CAS號 | 1110813-31-4 | 試劑別名 | (2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-哌啶基)-2-丁烯酰胺;達克替尼;(2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-;Dacomitinib (PF299804, PF299) 抑制劑;EGFR抑制劑;PF299804(EGFR抑制劑);達克替尼(804);達克替尼804粉末;達克替尼804固體狀;達克替尼804中間體;達克替尼pf-299804;達克替尼PF804;科研實驗達克替尼804;臨床實驗 達克替尼804;醫(yī)藥級達克替尼804;達克米替尼;達克替尼(Dacomitinib,PF299804);(E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基喹唑啉-6-基]-4-(哌啶-1-基)丁-2-烯酰胺 |
分子式 | C24H25ClFN5O2 | ||
分子量 | 469.94 | ||
英文名稱: | pf-299804 |
英文別名: | pf-299804;Dacomitinib;Dacomitinib (PF299804, PF299);(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;Dacomitinib (PF299804);PF299804;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide;(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide;Dacomitinib [USAN];Dacomitinib,PF299804;dacomitinib (pan-HER inhibitor);(2E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide;PF-00299804-03;PF-00299804;PF-299;(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide;PF 00299804 |
中文別名: | (2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-哌啶基)-2-丁烯酰胺;達克替尼;(2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-;Dacomitinib (PF299804, PF299) 抑制劑;EGFR抑制劑;PF299804(EGFR抑制劑);達克替尼(804);達克替尼804粉末;達克替尼804固體狀;達克替尼804中間體;達克替尼pf-299804;達克替尼PF804;科研實驗達克替尼804;臨床實驗 達克替尼804;醫(yī)藥級達克替尼804;達克米替尼;達克替尼(Dacomitinib,PF299804);(E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基喹唑啉-6-基]-4-(哌啶-1-基)丁-2-烯酰胺 |
CAS No.: | 1110813-31-4 |
分子式: | C24H25CLFN5O2 |
分子量: | 469.94 |
純度: | 99% |